###begin article-title 0
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Identification of two novel OPA1 mutations in Chinese families with autosomal dominant optic atrophy
###end article-title 0
###begin p 1
The first two authors contributed equally to this work.
###end p 1
###begin p 2
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin title 3
Purpose
###end title 3
###begin p 4
To report the clinical features and identification of two novel mutations in two Chinese pedigrees with autosomal dominant optic atrophy (ADOA).
###end p 4
###begin title 5
Methods
###end title 5
###begin p 6
###xml 327 331 327 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 442 446 442 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 194 206 <span type="species:ncbi:9606">participants</span>
###xml 591 598 <span type="species:ncbi:9606">patient</span>
###xml 823 831 <span type="species:ncbi:9606">patients</span>
Two families (F1 and F2) including ten affected members and nine unaffected family individuals were examined clinically. After informed consent was obtained, peripheral blood samples of all the participants were obtained, and genomic DNA was extracted. Linkage analysis was performed with two microsatellite markers around the OPA1 gene (D3S2305 and D3S3562) in family F1. The coding region (exon 1-28), including intron-exon boundary of the OPA1 gene, were screened in the 2 families by polymerase chain reaction (PCR) and direct DNA sequencing. Whenever substitutions were identified in a patient, single strand conformation polymorphism (SSCP) analysis was performed on all available family members and 100 normal controls. To characterize a splicing site mutation, RT-PCR of total RNA of leukocytes obtained from three patients and seven unaffected individuals of family F1 was performed with the specific primers.
###end p 6
###begin title 7
Results
###end title 7
###begin p 8
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
The affected individuals all presented with bilateral visual failure and temporal or total pallor of the optic discs. Genotyping of family F1 revealed the linkage to the OPA1 gene on 3q28-29. After sequencing of OPA1 gene, a novel heterozygous splicing site mutation c.985 -2A>G in intron 9 was found in family F1. RT-PCR result showed the skipping of the exon 10 in the mutant transcript, which results in loss of 27 amino acids in the OPA1 protein. A novel heterozygous nonsense mutation c.2197C>T(p.R733X)was detected in family F2.
###end p 8
###begin title 9
Conclusions
###end title 9
###begin p 10
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
Our findings expand the spectrum of OPA1 mutations and further established the role of OPA1 gene in Chinese patients with ADOA.
###end p 10
###begin title 11
Introduction
###end title 11
###begin p 12
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 678 679 678 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 680 681 680 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 732 736 732 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA3</italic>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 875 879 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA3</italic>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
Autosomal dominant optic atrophy (ADOA, OMIM ), also called Kjer type optic atrophy, is the most frequent form of inherited optic neuropathy with a prevalence of between 1:10,000 and 1:50,000 [1,2]. It is a disorder characterized by slowly progressive visual loss usually starting in childhood, color vision defects, centrocecal scotomas, and temporal optic nerve pallor [3]. The results of histopathological examinations of affected donor eyes suggest that the fundamental pathology is degeneration of the retinal ganglion cells and loss of myelin and nerve tissue within the optic nerve [4]. ADOA is genetic heterogeneous, and 4 chromosome loci for the ADOA have been mapped [5-8]. Of the 4 loci, only OPA1 gene (3q28-29) [5] and OPA3 gene (19q13) [7] have been identified. Mutations in the OPA1gene account for the majority of cases of ADOA [9,10], while mutations in the OPA3 gene cause ADOA with cataract [7].
###end p 12
###begin p 13
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 254 259 <span type="species:ncbi:9606">human</span>
The OPA1 gene on chromosome 3q28-29 consists of 28 coding exons and encodes a 960 amino acid polypeptide [9,10]. Due to alternative splicing of exon 4, 4b, 5b, the OPA1 gene has 8 mRNA splicing isoforms with different expression in different tissues. In human retina and brain, isoform 1 (missing exon 4b and 5b) and isoform 4 (missing exon 4 and 4b) have been shown to have the predominate expression [11]. OPA1 protein is a dynamin-related GTPase targeted to mitochondria, which locates mostly on the mitochondrial inner membrane [12,13]. OPA1 consists of 5 domains: mitochondrial target signal (MTS), N-terminal (N-terminal) coiled-coil domain, GTPase domain, dynamin central region, and C-terminal (C-terminal) coiled-coil domain [13]. OPA1 is thought to be involved in multiple functions, the key role being the regulation of mitochondrial dynamics, the maintenance of structural integrity of the cristae [12-14], and regulation of the apoptotic process through the control of cytochrome C redistribution [12-14].
###end p 13
###begin p 14
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 225 226 225 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
To date, more than 100 mutations have been reported in the OPA1 gene and most of them are localized to the N-terminal leader sequence (exon 1-2), the GTPase domain (exon 8-16), and C-terminal coiled-coil region (exon 27-28) [9-11,15-24].
###end p 14
###begin p 15
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
In this study, we performed a mutation screening of the OPA1 gene in two Chinese families affected with ADOA and identified two novel mutations.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and DNA samples collection
###end title 17
###begin p 18
###xml 208 219 <span type="species:ncbi:9606">participant</span>
###xml 291 303 <span type="species:ncbi:9606">participants</span>
This study was granted approval by the Beijing Tongren Hospital Joint Committee on Clinical Investigation and conformed to the tenets of the Declaration of Helsinki. After informed consent was obtained, each participant (two probands were examined in the Beijing TongRen Hospital, the other participants, including 14 individuals of family 1 and 3 members in family 2, were examined in their local town by Dr. Li and Dr.Tong) underwent clinical examinations including best-corrected visual acuity using E decimal charts, slit-lamp, and ophthalmoscope. Two probands of the families underwent visual field, pattern visual evoked potential (P-VEP), and color discrimination test. ADOA was diagnosed based on the clinical and family history, the bilateral visual loss, and temporal pallor of optic discs. Peripheral blood was obtained by venipuncture in heparinized collecting tube and kept in 4 degreesC less than one week, and genomic DNA was extracted according to standard phenol protocols.
###end p 18
###begin title 19
Linkage analysis
###end title 19
###begin p 20
###xml 110 114 110 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Genotyping and linkage analysis were performed with two microsatellite markers D3S2305 and D3S3562 around the OPA1 gene in family F1. The fine mapping primer sequences were obtained from the GDB . Pedigree and haplotype map were constructed using Cyrillic V. 2.0 software.
###end p 20
###begin title 21
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Mutation screening of the OPA1 gene
###end title 21
###begin p 22
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 231 238 231 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 771 775 771 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Mutation screening was performed in the two families using direct DNA sequence analysis. Primers of 1-28 exons and exon-intron boundaries of the OPA1 gene were designed by the  program. Details of the primer sequences are shown in Table 1. For direct sequencing, PCR products were purified (Shenneng Bocai PCR purification kit; Shenneng, Shanghai, China). The purified PCR products were sequenced using an automatic fluorescence DNA sequencer (ABI, Prism 373A; Perkin Elmer, Foster City, CA), according to the manufacturer's instructions. Nucleotide sequences were compared with the published DNA sequence of OPA1 isoform 1 (GenBank accession number ) using DNAssit Version 1.0. For OPA1 gene cDNA numbering +1 corresponds to A in the ATG translation initiation codon of OPA1 isoform 1.
###end p 22
###begin title 23
PCR primers used in this study
###end title 23
###begin title 24
Single strand conformation polymorphism
###end title 24
###begin p 25
###xml 610 612 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
To confirm the variations found in the sequencing, we conducted single strand conformation polymorphism (SSCP) analysis in all available family members and 100 normal controls. Amplified DNA was mixed with an equal volume formamide buffer that contained 95% formamide, 10 mM EDTA, 0.1% bromophenol blue, and 0.1% xylene cyanol. Denatured samples were electrophoresed on a 16% non-denaturing polyacrylamide gel (acrylamide:bisacrylamide=49:1) in Tris-borate-EDTA buffer (89 mM Tris base, 2 mM EDTA, and 89 mM Boric acid, pH 8.0) for 12-16 h at 300 v and 4 degreesC before gels were silver-stained and analyzed [25].
###end p 25
###begin title 26
Reverse transcription-polymerase chain reaction
###end title 26
###begin p 27
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Lymphocytes from peripheral blood were isolated from the 3 patients and 7 unaffected individuals of family F1. Total RNA was extracted with TRIZOL Reagent (Invitrogen, Carlsbad, CA). Reverse transcription of isolated RNA was performed using the First-Strand cDNA Synthesis Kit (Toyobo, Osaka, Japan) with random primers. The transcribed OPA1 fragment from exon 9 to exon 11 was amplified using the following primer pair: forward, 5'- TGG AGA TCA GAG TGC TGG AA-3'; and reverse, 5'- CTC AGG GCT AAC GGT ACA GC-3'. RT-PCR products were separated on a 1% agarose gel and sequenced.
###end p 27
###begin title 28
Results
###end title 28
###begin title 29
Clinical findings
###end title 29
###begin p 30
###xml 201 209 201 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 387 395 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 728 735 728 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 749 761 <span type="species:ncbi:9606">participants</span>
We have identified two unrelated Chinese families consisting of 10 patients and 9 unaffected relatives diagnosed with optic atrophy. The inheritance pattern in the two families was autosomal dominant (Figure 1). All the patients had experienced bilateral vision acuity impairment at their childhood. The ophthalmoscope demonstrated bilateral temporal or total pallor of the optic discs (Figure 2). Pseudoisochromatic plates test showed red-green color weakness. The two probands had P-VEP recordings with the decreased amplitude and prolonged latency of P100 wave. Octopus visual field of the proband in family F2 showed bilateral central scotoma. Detailed clinical information of each family's affected member is summarized in Table 2. None of the participants from either family presented with hearing loss, cataract, ptosis, or ophthalmoplegia.
###end p 30
###begin p 31
Family structure and haplotype analysis of the two Chinese families with ADOA. Pedigree of the two families with autosomal dominant optic atrophy (ADOA) and haplotype analysis of the family F1 showed segregation two microsatellite markers on chromosome 3 listed in descending order from the centromeric end. Squares indicate males; circles indicate females; slashed symbols indicate deceased; solid symbols indicate affected; open symbols indicate unaffected; and arrow symbol indicates proband.
###end p 31
###begin p 32
###xml 23 30 <span type="species:ncbi:9606">patient</span>
Fundus appearance of a patient with autosomal dominant optic atrophy (ADOA). Fundus of proband of family F2 showed bilateral temporal pallor of optic discs.
###end p 32
###begin title 33
Clinical features of family members in the two families
###end title 33
###begin p 34
###xml 252 264 <span type="species:ncbi:9606">participants</span>
Abbreviations: male (M), female (F), total optic disc pallor (A), temporal optic disc pallor (T), normal (N), and no light perception (NLP). The asterisk indicates the eyeball had atrophied due to a corneal penetrating trauma. Clinical features of all participants from the two families with ADOA were summarized in this table.
###end p 34
###begin title 35
Genotyping results
###end title 35
###begin p 36
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Family F1 was genotyped with two short tandem repeat polymorphism (STRP) markers located around the OPA1 gene in the 3q28-29 region. The marker results for D3S2305 and D3S3562 were fully informative for linkage. There was no affected recombinant for either of the 2 markers (Figure 1). Although a meiotic breakpoint was observed in an unaffected family member (III:7), the marker D3S2305 was very close to the OPA1 locus, whereas marker D3S3562 was further telomeric and did not comprise any part of the OPA1 gene. However, one clinical unaffected individual (III: 2) carried the affected haplotype.
###end p 36
###begin title 37
Mutation analysis
###end title 37
###begin p 38
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 188 196 188 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
After sequencing the OPA1 gene, we identified two novel heterozygous mutations: a splicing site mutation c.985 -2A>G in family F1 and a nonsense mutation c.2197C>T (p.R733X) in family F2 (Figure 3). Using SSCP analysis, we found that these heterozygous mutations cosegregated with all affected members and the affected haplotype carrier, but we did not detect them in 100 unrelated normal controls.
###end p 38
###begin p 39
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 66 68 66 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 136 138 136 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
Direct sequencing analysis of the coding region of the OPA1 gene. A. Sequence shows the heterozygous splicing site mutation c.985-2A>G; B: Sequence shows the heterozygous nonsense mutation c.2197C>T (p. R733X). The 2 sequences given are in sense direction.
###end p 39
###begin p 40
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 356 364 356 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 500 508 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
To test whether the splice-site mutation lead to a defective mRNA, we performed an RT-PCR assay to amplify OPA1 mRNA from total RNA isolated from peripheral blood of the 3 patients and 7 normal individuals. Two fragments (about 270 bp and 189 bp) were obtained from the patients, while only 1 fragment (about 270 bp) was obtained from the normal controls (Figure 4). The results of sequencing revealed that the 270 bp fragment was normal; however, the 189 bp fragment showed the skipping of exon 10 (Figure 4).
###end p 40
###begin p 41
###xml 79 81 79 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 278 279 278 279 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 284 286 284 286 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 367 369 367 369 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 428 430 428 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 340 347 <span type="species:ncbi:9606">patient</span>
RT-PCR and direct sequencing analysis for the splice site mutation c.985-2A>G. A: Ethidium bromide-agarose gel was loaded with RT-PCR products generated from leukocytes of total RNA of three affected members (two bands) and seven unaffected individuals (one band) of family F1. B and C: The sequence chromatograms of the two bands from the patient's RT-PCR products; B: The mutant transcript sequence with the skipping exon 10. C: The corresponding normal transcript sequence between exon 9 and exon 11.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
In this study, we examined two Chinese families with clinically diagnosed ADOA and screened the OPA1 gene. We identified a novel heterozygous splicing site mutation c.985-2A>G and a novel heterozygous nonsense mutation c.2197C>T (p.R733X). The 2 novel mutations cosegregated with the disease phenotype and were not detected in 100 normal controls.
###end p 43
###begin p 44
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 71 73 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 887 888 887 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 127 135 <span type="species:ncbi:9606">patients</span>
To date, more than 100 OPA1 gene mutations have been reported [9-11,15-24]; however, only 2 mutations were reported in Chinese patients. The 2 mutations, a missense p.G401D and a small deletion p. D950CfsX4, are associated with a complex clinical phenotype characterized by ADOA with sensorineural deafness [21,22]. Therefore, the current study is the first report of mutations causing isolate ADOA in Chinese families. Among the mutations reported, more than 20% of them are splice site mutations, which are presumed to result in the in-frame skipping of exons or premature termination of OPA1 translation. The novel splice-site mutation c.985-2A>G detected in family F1 causes an in-frame skipping of exon 10, which encodes 27 amino acids in the highly conserved GTPase domain of OPA1 protein. Delettre et al. reported a recurrent mutation c.985-1G>A, which has a similar consequence [9,11]. This may suggest that the segment encoded by the exon 10 is critical for the GTPase activity of OPA1, and the exon 10 splice acceptor site may be a mutation hot spot.
###end p 44
###begin p 45
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 624 628 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 689 691 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
In our review of the literature, we found ADOA displays great variability in phenotypic expression. It was originally thought that penetrance was almost complete (98%) [16]. However, the subsequent molecular analysis revealed that the disease penetrance is much lower. Revised estimates of penetrance have varied between 43% and 62% for different OPA1 mutation [16]. Previously, only visual acuity and optic disc appearance were used to classify a mutation carrier penetrant [16]. Cohn et al. extended the clinical parameters to include color vision and visual field assessment, and observed that the overall penetrance for OPA1 mutations in the large Australian ADOA pedigrees was 82.5% [23]. Using this clinical standard, they recalculated the penetrance of 2 families harboring c.2708del (TTAG) mutation previously reported by Toomes et al. [16]. The recalculated penetrance of the two families was 66% and 67% [23], which was higher than the original 43% and 62% [16]. In the current study, one clinically unaffected member of family F1 carried the mutation c.985-2A>G; he was also found to harbor the affected haplotype. The penetrance of ADOA for family F1 was 87.5% (7/8). The limitation of the study was that only visual acuity and optic disc appearances were used to classify the mutation carrier penetrant.
###end p 45
###begin p 46
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 775 777 775 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 857 861 857 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 951 955 951 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
The novel nonsense mutation c.2197C>T (p.R733X) detected in family F2 presumably caused premature termination of the OPA1 translation. The predicted effect of this mutation would be a truncated protein lacking the 227 amino acids, accounting for loss of 26.6% of OPA1, including the part of central dynamin domain and total coiled-coil region at the C-terminus. As the premature stop codons are not located in the last exon of the OPA1 gene, there is a possibility that nonsense-mediated mRNA decay (NMD) might be involved in the abnormal RNAs processing. NMD is a widespread cellular process that proofreads nascent mRNA transcripts and destroys those that bear premature termination codons before they are actually translated in truncated and potentially harmful proteins [26]. In a recent study, Schimpf et al. demonstrated that the majority of nonsense OPA1 mutations underwent NMD. Using pyrosequencing of an RT-PCR amplified cSNP (c.2109C>T) in OPA1, they found that mutant transcript levels reduced between 1.25- and 2.5-fold and varied among premature termination codons containing mutations [24].
###end p 46
###begin p 47
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
In conclusion, we described 2 novel mutations of the OPA1 gene in Chinese ADOA families. Our findings expand the spectrum of OPA1 gene mutation and provided useful genetic consultation and genetic diagnosis for the families.
###end p 47
###begin title 48
Acknowledgments
###end title 48
###begin p 49
###xml 13 21 <span type="species:ncbi:9606">patients</span>
We thank the patients and their families for participation in this study.
###end p 49
###begin title 50
References
###end title 50
###begin article-title 51
Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects.
###end article-title 51
###begin article-title 52
Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.
###end article-title 52
###begin article-title 53
A clinicopathologic study of autosomal dominant optic atrophy.
###end article-title 53
###begin article-title 54
Dominant optic atrophy (OPA1) mapped to chromosome 3q region I. Linkage analysis.
###end article-title 54
###begin article-title 55
Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12.2-12.3.
###end article-title 55
###begin article-title 56
OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.
###end article-title 56
###begin article-title 57
A third locus for dominant optic atrophy on chromosome 22q.
###end article-title 57
###begin article-title 58
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy.
###end article-title 58
###begin article-title 59
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28.
###end article-title 59
###begin article-title 60
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Mutation spectrum and splicing variants in the OPA1 gene.
###end article-title 60
###begin article-title 61
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space.
###end article-title 61
###begin article-title 62
Differential sublocalization of the dynamin-related protein OPA1 isoforms in mitochondria.
###end article-title 62
###begin article-title 63
Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.
###end article-title 63
###begin article-title 64
OPA1 mutations and mitochondrial DNA haplotypes in autosomal dominant optic atrophy.
###end article-title 64
###begin article-title 65
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.
###end article-title 65
###begin article-title 66
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 18 26 <span type="species:ncbi:9606">patients</span>
OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.
###end article-title 66
###begin article-title 67
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
###end article-title 67
###begin article-title 68
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy.
###end article-title 68
###begin article-title 69
eOPA1: An Online Database for OPA1 Mutations.
###end article-title 69
###begin article-title 70
The G401D mutation of OPA1 causes autosomal dominant optic atrophy and hearing loss in a Chinese family.
###end article-title 70
###begin article-title 71
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
A novel OPA1mutation responsible for autosomal dominant optic atrophy with high frequency hearing loss in a Chinese family.
###end article-title 71
###begin article-title 72
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
Autosomal dominant optic atrophy: Penetrance and expressivity in patients with OPA1 mutations.
###end article-title 72
###begin article-title 73
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPA1</italic>
Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature termination codons.
###end article-title 73
###begin article-title 74
Fast and sensitive silver staining of DNA in polyacrylamide gels.
###end article-title 74
###begin article-title 75
A perfect message: RNA surveillance and nonsense-mediated decay.
###end article-title 75

